'These are for premature babies and infants dealing with food allergies and sensitivities,' said MyOr co-founder and chief technology officer Michael Brandwein.
After Pfizer announces 90% effectiveness of its clinical trial, Israel asks the U.S. government for doses of the vaccine once it's approved by the FDA.
An Israeli Professor has developed a unique biomechanical method for the early detection of metastatic (secondary) cancer, and Israeli students have developed a new imaging method for gallbladder removal.
The FDA recently approved a groundbreaking new non-invasive, radiation-free lung imaging system created by Deep Breeze, Ltd, an Israeli company in Or Akiva.
Join More than
11,498,929
United With Israel
You will receive updates from Israel (see privacy policy)